These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34976787)

  • 1. Coagulation Factor XIII Subunit A Is a Biomarker for Curative Effects and Prognosis in Malignant Solid Tumors, Especially Non-small Cell Lung Cancer.
    Luo Y; Li B; Li J; Zhang Y; Deng M; Hu C; Yan W; Zhou Z; Zhang G
    Front Oncol; 2021; 11():719085. PubMed ID: 34976787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships of coagulation factor XIII activity with cell-type and stage of non-small cell lung cancer.
    Lee SH; Suh IB; Lee EJ; Hur GY; Lee SY; Lee SY; Shin C; Shim JJ; In KH; Kang KH; Yoo SH; Kim JH
    Yonsei Med J; 2013 Nov; 54(6):1394-9. PubMed ID: 24142643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocytes of patients congenitally deficient in plasma factor XIII lack factor XIII subunit a antigen and transglutaminase activity.
    Muszbek L; Adány R; Kávai M; Boda Z; Lopaciuk S
    Thromb Haemost; 1988 Apr; 59(2):231-5. PubMed ID: 2898817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of blood coagulation factor XIII in patients with acute pulmonary embolism. Correlation of factor XIII antigen levels with pulmonary occlusion rate, fibrinogen, D-dimer, and clot firmness.
    Kucher N; Schroeder V; Kohler HP
    Thromb Haemost; 2003 Sep; 90(3):434-8. PubMed ID: 12958612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelets but not monocytes contribute to the plasma levels of factor XIII subunit A in patients undergoing autologous peripheral blood stem cell transplantation.
    Inbal A; Muszbek L; Lubetsky A; Katona E; Levi I; Kárpáti L; Nagler A
    Blood Coagul Fibrinolysis; 2004 Apr; 15(3):249-53. PubMed ID: 15060422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subunit antigen and activity levels of blood coagulation factor XIII in healthy individuals. Relation to sex, age, smoking, and hypertension.
    Ariëns RA; Kohler HP; Mansfield MW; Grant PJ
    Arterioscler Thromb Vasc Biol; 1999 Aug; 19(8):2012-6. PubMed ID: 10446086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor XIII levels and factor XIII B subunit polymorphisms in patients with venous thromboembolism.
    Mezei ZA; Katona É; Kállai J; Bereczky Z; Somodi L; Molnár É; Kovács B; Miklós T; Ajzner É; Muszbek L
    Thromb Res; 2017 Oct; 158():93-97. PubMed ID: 28865246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced levels of coagulation factor XIII in patients with advanced tumor disease.
    Born P; Lippl F; Ulm K; Gerein P; Lersch C; Eckel F; Fischer G; Sandschin W; Dlaska U; Classen M
    Hepatogastroenterology; 2000; 47(31):194-8. PubMed ID: 10690608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of coagulation factor XIII on bleeding risk in ischemic stroke patients treated with intravenous thrombolysis.
    Zhang L; Zhang C; Luo Y; Tang N
    Ann Palliat Med; 2021 Jul; 10(7):7579-7586. PubMed ID: 34353045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics of coagulation factor XIII activity after video-assisted thoracoscopic lobectomy for non-small cell lung cancer.
    Shirai S; Yamauchi Y; Yokote F; Sakai T; Saito Y; Sakao Y; Kawamura M
    J Thorac Dis; 2019 Dec; 11(12):5382-5389. PubMed ID: 32030256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor XIII topology: organization of B subunits and changes with activation studied with single-molecule atomic force microscopy.
    Protopopova AD; Ramirez A; Klinov DV; Litvinov RI; Weisel JW
    J Thromb Haemost; 2019 May; 17(5):737-748. PubMed ID: 30773828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid immunochromatographic test for detection of anti-factor XIII A subunit antibodies can diagnose 90 % of cases with autoimmune haemorrhaphilia XIII/13.
    Osaki T; Sugiyama D; Magari Y; Souri M; Ichinose A
    Thromb Haemost; 2015 Jun; 113(6):1347-56. PubMed ID: 25740658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal factor XIII activity level to prevent major spontaneous bleeds.
    Menegatti M; Palla R; Boscarino M; Bucciarelli P; Muszbek L; Katona E; Makris M; Peyvandi F;
    J Thromb Haemost; 2017 Sep; 15(9):1728-1736. PubMed ID: 28688221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor XIII A-subunit concentration predicts outcome in stroke subjects and vascular outcome in healthy, middle-aged men.
    Kohler HP; Ariëns RA; Catto AJ; Carter AM; Miller GJ; Cooper JA; Mansfield MW; Standeven KF; Grant PJ
    Br J Haematol; 2002 Sep; 118(3):825-32. PubMed ID: 12181053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic and intestinal levels of factor XIII-A: the impact of inflammation on expression in macrophage subtypes.
    Soendergaard C; Kvist PH; Seidelin JB; Pelzer H; Nielsen OH
    J Gastroenterol; 2016 Aug; 51(8):796-807. PubMed ID: 26660730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological coagulation parameters in as many as 54 patients with autoimmune acquired factor XIII deficiency due to anti-factor XIII autoantibodies.
    Ichinose A; Osaki T; Souri M
    Haemophilia; 2021 May; 27(3):454-462. PubMed ID: 33847063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel aspects of blood coagulation factor XIII. I. Structure, distribution, activation, and function.
    Muszbek L; Adány R; Mikkola H
    Crit Rev Clin Lab Sci; 1996; 33(5):357-421. PubMed ID: 8922891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of factor XIII-A in patients with chronic rhinosinusitis with nasal polyps.
    Takabayashi T; Kato A; Peters AT; Hulse KE; Suh LA; Carter R; Norton J; Grammer LC; Tan BK; Chandra RK; Conley DB; Kern RC; Fujieda S; Schleimer RP
    J Allergy Clin Immunol; 2013 Sep; 132(3):584-592.e4. PubMed ID: 23541322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reduction of FXIII during myelosuppression in acute leukemia after chemotherapy and adverse relation with bleeding events].
    Wang YZ; Tan BY; Li L; Li ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2020 Jan; 41(1):59-63. PubMed ID: 32023756
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy and safety of prophylactic treatment with plasma-derived factor XIII concentrate (human) in patients with congenital factor XIII deficiency.
    Ashley C; Chang E; Davis J; Mangione A; Frame V; Nugent DJ
    Haemophilia; 2015 Jan; 21(1):102-8. PubMed ID: 25377187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.